Mr Behnam B Badie, MD | |
301 W Huntington Dr Ste 400, Arcadia, CA 91007-3471 | |
(626) 574-3657 | |
Not Available |
Full Name | Mr Behnam B Badie |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 35 Years |
Location | 301 W Huntington Dr Ste 400, Arcadia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114026846 | NPI | - | NPPES |
00G705930 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | G70593 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
City Of Hope Medical Foundation | 3779751656 | 686 |
News Archive
Increasing margin distance up to 15 mm significantly decreases the risk of local recurrence among patients undergoing wedge resection for early-stage, non-small-cell lung cancer, US researchers report.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
Today, Thomas Jefferson University announces a partnership with Exosome Sciences Inc. to evaluate a novel liquid biopsy platform that might offer clinicians new and actionable information about a patient's cancer as the disease progresses and changes, via a simple blood test.
A team of researchers at the Institute of Oncology Research has identified a new class of regulatory RNAs, which are able to act as molecular switches and can contribute in controlling the genetic evolution processes that are responsible for some cancer pathologies.
Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical, said today.
› Verified 4 days ago
Entity Name | City Of Hope Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244 |
News Archive
Increasing margin distance up to 15 mm significantly decreases the risk of local recurrence among patients undergoing wedge resection for early-stage, non-small-cell lung cancer, US researchers report.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
Today, Thomas Jefferson University announces a partnership with Exosome Sciences Inc. to evaluate a novel liquid biopsy platform that might offer clinicians new and actionable information about a patient's cancer as the disease progresses and changes, via a simple blood test.
A team of researchers at the Institute of Oncology Research has identified a new class of regulatory RNAs, which are able to act as molecular switches and can contribute in controlling the genetic evolution processes that are responsible for some cancer pathologies.
Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical, said today.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Behnam B Badie, MD Po Box 512185, Los Angeles, CA 90051-0185 Ph: (626) 775-3514 | Mr Behnam B Badie, MD 301 W Huntington Dr Ste 400, Arcadia, CA 91007-3471 Ph: (626) 574-3657 |
News Archive
Increasing margin distance up to 15 mm significantly decreases the risk of local recurrence among patients undergoing wedge resection for early-stage, non-small-cell lung cancer, US researchers report.
FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.
Today, Thomas Jefferson University announces a partnership with Exosome Sciences Inc. to evaluate a novel liquid biopsy platform that might offer clinicians new and actionable information about a patient's cancer as the disease progresses and changes, via a simple blood test.
A team of researchers at the Institute of Oncology Research has identified a new class of regulatory RNAs, which are able to act as molecular switches and can contribute in controlling the genetic evolution processes that are responsible for some cancer pathologies.
Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical, said today.
› Verified 4 days ago
Dr. Gregory J. Withers, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Drive, Suite 407, Arcadia, CA 91007 Phone: 626-821-3440 Fax: 626-821-0709 | |
Dr. Mike Y Chen, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr Ste 400, Arcadia, CA 91007 Phone: 626-574-3657 |